Molecular design and synthesis of self-assembling camptothecin drug amphiphiles

Acta Pharmacologica Sinica

Volumn 38, Issue 6, 2017, Pages 874-884

  Cheetham, Andrew G ^a   Lin, Yi An ^a   Lin, Ran ^a   Cui, Honggang ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Camptothecin; Chemotherapy; Drug amphiphiles; Nanomedicine; Peptides; Prodrugs; Self assembly

Indexed keywords

AMPHOPHILE; CAMPTOTHECIN; NANOMATERIAL; PEPTIDE; PRODRUG; ANTINEOPLASTIC AGENT; SURFACTANT;

AMINO ACID SEQUENCE; ARTICLE; DEGRADATION; DRUG CONJUGATION; DRUG DESIGN; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; PURIFICATION; REACTION TIME; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOSPECIFICITY; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; DRUG DESIGN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR STRUCTURE; PEPTIDES; SURFACE-ACTIVE AGENTS;

EID: 85020214092     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2016.151     Document Type: Article

References (83)

1. Lien S, Lowman HB. Therapeutic peptides. Trends Biotechnol 2003; 21: 556-62.
2. Albericio F, Kruger HG. Therapeutic peptides. Future Med Chem 2012; 4: 1527-31.
3. Ahrens VM, Bellmann-Sickert K, Beck-Sickinger AG. Peptides and peptide conjugates: therapeutics on the upward path. Future Med Chem 2012; 4: 1567-86.
4. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998; 279: 377-80.
5. Burkhart DJ, Kalet BT, Coleman MP, Post GC, Koch TH. Doxorubicin-formaldehyde conjugates targeting v3 integrin. Mol Cancer Ther 2004; 3: 1593-604.
6. Wang S, Placzek WJ, Stebbins JL, Mitra S, Noberini R, Koolpe M, et al. Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells. J Med Chem 2012; 55: 2427-36.
7. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005; 57: 559-77.
8. Dubikovskaya EA, Thorne SH, Pillow TH, Contag CH, Wender PA. Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proc Natl Acad Sci U S A 2008; 105: 12128-33.
9. Soukasene S, Toft DJ, Moyer TJ, Lu HM, Lee HK, Standley SM, et al. Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin. ACS Nano 2011; 5: 9113-21.
10. Zhang PC, Cheetham AG, Lock LL, Cui HG. Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site. Bioconjugate Chem 2013; 24: 604-13.
11. Wang Y, Cheetham AG, Angacian G, Su H, Xie L, Cui H. Peptide-drug conjugates as effective prodrug strategies for targeted delivery. Adv Drug Deliv Rev 2016; pii: S0169-409X(16)30208-3.
12. Lin R, Zhang PC, Cheetham AG, Walston J, Abadir P, Cui HG. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting. Bioconjugate Chem 2015; 26: 71-7.
13. Zompra AA, Galanis AS, Werbitzky O, Albericio F. Manufacturing peptides as active pharmaceutical ingredients. Future Med Chem 2009; 1: 361-77.
14. Su H, Koo JM, Cui HG. One-component nanomedicine. J Control Release 2015; 219: 383-95.
15. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001; 294: 1684-8.
16. Rajangam K, Behanna HA, Hui MJ, Han XQ, Hulvat JF, Lomasney JW, et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett 2006; 6: 2086-90.
17. Standley SM, Toft DJ, Cheng H, Soukasene S, Chen J, Raja SM, et al. Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res 2010; 70: 3020-6.
18. Pakalns T, Haverstick KL, Fields GB, McCarthy JB, Mooradian DL, Tirrell M. Cellular recognition of synthetic peptide amphiphiles in self-assembled monolayer films. Biomaterials 1999; 20: 2265-79.
19. Trent A, Marullo R, Lin B, Black M, Tirrell M. Structural properties of soluble peptide amphiphile micelles. Soft Matter 2011; 7: 9572-82.
20. Jun HW, Yuwono V, Paramonov SE, Hartgerink JD. Enzyme-mediated degradation of peptide-amphiphile nanofiber networks. Adv Mater 2005; 17: 2612-7.
21. Gauba V, Hartgerink JD. Self-assembled heterotrimeric collagen triple helices directed through electrostatic interactions. J Am Chem Soc 2007; 129: 2683-90.
22. Toledano S, Williams RJ, Jayawarna V, Ulijn RV. Enzyme-triggered self-assembly of peptide hydrogels via reversed hydrolysis. J Am Chem Soc 2006; 128: 1070-1.
23. Smith AM, Williams RJ, Tang C, Coppo P, Collins RF, Turner ML, et al. Fmoc-Diphenylalanine self assembles to a hydrogel via a novel architecture based on pi-pi interlocked beta-sheets. Adv Mater 2008; 20: 37-41.
24. Ceylan H, Tekinay AB, Guler MO. Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface. Biomaterials 2011; 32: 8797-805.
25. Cinar G, Ceylan H, Urel M, Erkal TS, Tekin ED, Tekinay AB, et al. Amyloid inspired self-assembled peptide nanofibers. Biomacromolecules 2012; 13: 3377-87.
26. Schneider JP, Pochan DJ, Ozbas B, Rajagopal K, Pakstis L, Kretsinger J. Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. J Am Chem Soc 2002; 124: 15030-7.
27. Li JY, Kuang Y, Gao Y, Du XW, Shi JF, Xu B. D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID). J Am Chem Soc 2013; 135: 542-5.
28. Cheetham AG, Keith D, Zhang PC, Lin R, Su H, Cui HG. Targeting tumors with small molecule peptides. Curr Cancer Drug Targets 2016; 16: 489-508.
29. Su H, Zhang PC, Cheetham AG, Koo JM, Lin R, Masood A, et al. Supramolecular crafting of self-assembling camptothecin prodrugs with enhanced efficacy against primary cancer cells. Theranostics 2016; 6: 1065-74.
30. Lock LL, Tang Z, Keith D, Reyes C, Cui HG. Enzyme-specific doxorubicin drug beacon as drug-resistant theranostic molecular probes. ACS Macro Lett 2015; 4: 552-5.
31. Sievers EL, Linenberger M. Mylotarg: Antibody-targeted chemotherapy comes of age. Curr Opin Oncol 2001; 13: 522-7.
32. Younes A, Yasothan U, Kirkpatrick P. Brentuximab vedotin. Nat Rev Drug Discov 2012; 11: 19-20.
33. Traynor K. Ado-trastuzumab emtansine approved for advanced breast cancer. Am J Health Sys Pharm 2013; 70: 562.
34. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discov Today 2010; 15: 40-56.
35. Tang L, Persky AM, Hochhaus G, Meibohm B. Pharmacokinetic aspects of biotechnology products. J Pharm Sci 2004; 93: 2184-204.
36. Evans WE, Relling MV. Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. Clin Pharmacokinet 1989; 16: 327-36.
37. Undevia SD, Gomez-Abuin G, Ratain MJ. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer 2005; 5: 447-58.
38. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006; 6: 688-701.
39. Tong R, Cheng J. Anticancer polymeric nanomedicines. Polym Rev 2007; 47: 345-81.
40. Cheng JJ, Khin KT, Jensen GS, Liu AJ, Davis ME. Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates. Bioconjugate Chem 2003; 14: 1007-17.
41. Zou J, Jafr G, Themistou E, Yap Y, Wintrob ZAP, Alexandridis P, et al. pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization. Chem Commun 2011; 47: 4493-5.
42. Yu Y, Chen CK, Law WC, Mok J, Zou J, Prasad PN, et al. Well-defined degradable brush polymer-drug conjugates for sustained delivery of paclitaxel. Mol Pharm 2013; 10: 867-74.
43. Gao Y, Kuang Y, Guo ZF, Guo ZH, Krauss IJ, Xu B. Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative. J Am Chem Soc 2009; 131: 13576-7.
44. Shen Y, Jin E, Zhang B, Murphy CJ, Sui M, Zhao J, et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 2010; 132: 4259-65.
45. Cheetham AG, Zhang P, Lin YA, Lock LL, Cui H. Supramolecular nanostructures formed by anticancer drug assembly. J Am Chem Soc 2013; 135: 2907-10.
46. Lin R, Cheetham AG, Zhang P, Lin YA, Cui H. Supramolecular filaments containing a fixed 41% paclitaxel loading. Chem Commun (Camb) 2013; 49: 4968-70.
47. Li XY, Yang CB, Zhang ZL, Wu ZD, Deng Y, Liang GL, et al. Folic acid as a versatile motif to construct molecular hydrogelators through conjugations with hydrophobic therapeutic agents. J Mater Chem 2012; 22: 21838-40.
48. Wang HM, Wei J, Yang CB, Zhao HY, Li DX, Yin ZN, et al. The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol. Biomaterials 2012; 33: 5848-53.
49. McDaniel JR, Bhattacharyya J, Vargo KB, Hassouneh W, Hammer DA, Chilkoti A. Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation. Angew Chem Int Ed 2013; 52: 1683-7.
50. Lock LL, Reyes CD, Zhang PC, Cui HG. Tuning cellular uptake of molecular probes by rational design of their assembly into supramolecular nanoprobes. J Am Chem Soc 2016; 138: 3533-40.
51. Lin R, Cui HG. Supramolecular nanostructures as drug carriers. Curr Opin Chem Eng 2015; 7: 75-83.
52. Hu XY, Liu X, Zhang WY, Qin S, Yao CH, Li Y, et al. Controllable construction of biocompatible supramolecular micelles and vesicles by water-soluble phosphate pillar 5,6 arenes for selective anti-cancer drug delivery. Chem Mater 2016; 28: 3778-88.
53. Tan XY, Lu XG, Jia F, Liu XF, Sun YH, Logan JK, et al. Blurring the role of oligonucleotides: spherical nucleic acids as a drug delivery vehicle. J Am Chem Soc 2016; 138: 10834-7.
54. Sun Y, Kaplan JA, Shieh A, Sun HL, Croce CM, Grinstaff MW, et al. Self-assembly of a 5-fluorouracil-dipeptide hydrogel. Chem Commun 2016; 52: 5254-7.
55. Sun Y, Shieh A, Kim SH, King S, Kim A, Sun HL, et al. The self-assembly of a camptothecin-lysine nanotube. Bioorg Med Chem Lett 2016; 26: 2834-8.
56. Zhou Z, Munyaradzi O, Xia X, Green D, Bong D. High-capacity drug carriers from common polymer amphiphiles. Biomacromolecules 2016; 17: 3060-6.
57. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6: 789-802.
58. Cheetham AG, Ou YC, Zhang PC, Cui HG. Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles. Chem Commun 2014; 50: 6039-42.
59. Kang M, Zhang PC, Cui HG, Loverde SM. pi-pi Stacking mediated chirality in functional supramolecular filaments. Macromolecules 2016; 49: 994-1001.
60. Cui HG, Webber MJ, Stupp SI. Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 2010; 94: 1-18.
61. Hauser CAE, Zhang S. Designer self-assembling peptide nanofiber biological materials. Chem Soc Rev 2010; 39: 2780-90.
62. Kimura S, Kim DH, Sugiyama J, Imanishi Y. Vesicular self-assembly of a helical peptide in water. Langmuir 1999; 15: 4461-3.
63. Santoso S, Hwang W, Hartman H, Zhang SG. Self-assembly of surfactant-like peptides with variable glycine tails to form nanotubes and nanovesicles. Nano Lett 2002; 2: 687-91.
64. Jaracz S, Chen J, Kuznetsova LV, Ojima L. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005; 13: 5043-54.
65. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008; 60: 1615-26.
66. Peng MY, Qin SY, Jia HZ, Zheng DW, Rong L, Zhang XZ. Self-delivery of a peptide-based prodrug for tumor-targeting therapy. Nano Res 2016; 9: 663-73.
67. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 2010; 49: 6288-308.
68. Sosnik A. Drug self-assembly: A phenomenon at the nanometer scale with major impact in the structure-biological properties relationship and the treatment of disease. Prog Mater Sci 2016; 82: 39-82.
69. MacKay JA, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater 2009; 8: 993-9.
70. Dubowchik GM, Firestone RA. Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin. Bioorg Med Chem Lett 1998; 8: 3341-6.
71. Dubowchik GM, Mosure K, Knipe JO, Firestone RA. Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Ttaxol (R)), mitomycin C and doxorubicin. Bioorg Med Chem Lett 1998; 8: 3347-52.
72. Cheng R, Feng F, Meng F, Deng C, Feijen J, Zhong Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release 2011; 152: 2-12.
73. Zhong T, Huang R, Tan LJ. Amphiphilic drug-drug assembly via dual-responsive linkages for small-molecule anticancer drug delivery. RSC Advances 2016; 6: 66420-30.
74. Andreu D, Albericio F, Sole NA, Munson MC, Ferrer M, Barany G. Formation of disulfide bonds in synthetic peptides and proteins. Meth Mol Biol 1994; 35: 91-169.
75. Hoyle CE, Bowman CN. Thiol-ene click chemistry. Angew Chem Int Ed 2010; 49: 1540-73.
76. Lutz JF, Zarafshani Z. Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne "click" chemistry. Adv Drug Deliv Rev 2008; 60: 958-70.
77. Goux WJ, Kopplin L, Nguyen AD, Leak K, Rutkofsky M, Shanmuganandam VD, et al. The formation of straight and twisted filaments from short tau peptides. J Biol Chem 2004; 279: 26868-75.
78. Hu Y, Lin R, Patel K, Cheetham AG, Kan CY, Cui HG. Spatiotemporal control of the creation and immolation of peptide assemblies. Coord Chem Rev 2016; 320: 2-17.
79. Cheetham AG, Zhang P, Lin YA, Lin R, Cui H. Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin. J Mater Chem B 2014; 2: 7316-26.
80. Lin YA, Cheetham AG, Zhang PC, Ou YC, Li YG, Liu GS, et al. Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles. ACS Nano 2014; 8: 12690-700.
81. Du XW, Zhou J, Shi JF, Xu B. Supramolecular hydrogelators and hydrogels: from soft matter to molecular biomaterials. Chem Rev 2015; 115: 13165-307.
82. Luo Y, Li M, Zhao YW, Liu H, Gong TX, Hong Y, et al. Molecular nanofibers of paclitaxel form supramolecular hydrogel for preventing tumor growth in vivo. RSC Advances 2016; 6: 80847-50.
83. Peltier R, Chen GC, Lei HP, Zhang M, Gao LQ, Lee SS, et al. The rational design of a peptide-based hydrogel responsive to H2S. Chem Commun 2015; 51: 17273-6.